Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis

Overview of attention for article published in Frontiers in oncology, June 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,899 followers.

RT @FrontOncology: New research: Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis: Intro…

25 Jun 2023

Reply Repost Favourite

New research: Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis: Introduction Recent clinical trials have confirmed that anti-programmed cell death-1/ligand 1 (anti-PD-1/L1) combined with… #oncology https:

25 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.